I agree that this site is using cookies. You can find further informations here.
X
Rawal, Shalin
6  results:
Search for persons X
?
1

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus..:

Rawal, Shalin ; Sharma, Kamal ; Shah, Aditya...
Frontiers in Cardiovascular Medicine.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
2

Commentary: Beyond 10-year risk: A cost-effectiveness analy..:

Shah, Aditya ; Sharma, Kamal ; Rawal, Shalin...
Frontiers in Cardiovascular Medicine.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
3

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus..:

Rawal, Shalin ; Sharma, Kamal ; Shah, Aditya...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260166/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Commentary: Beyond 10-year risk: A cost-effectiveness analy..:

Aditya Shah ; Kamal Sharma ; Shalin Rawal...
https://www.frontiersin.org/articles/10.3389/fcvm.2022.916695/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
5

Table_1_Commentary: Cost-Effectiveness Analysis of Rivaroxa..:

Shalin Rawal ; Kamal Sharma ; Aditya Shah...
doi:10.3389/fcvm.2022.916705.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
6

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus..:

Shalin Rawal ; Kamal Sharma ; Aditya Shah...
https://www.frontiersin.org/articles/10.3389/fcvm.2022.916705/full.  , 2022
Link: https://doi.org/10.3389/..
 
1-6